This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.
Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options… More »
Meeting News Coverage Video
February 20, 2015
NASHVILLE, Tenn. — In this video, Larry B. Goldstein, MD, FAAN, FANA, FAHA, professor of neurology and director… More »
This activity is supported by an educational grant from Amgen, Inc.
Appropriate therapies for various dyslipidemias remain a challenge for practitioners struggling to reduce residual risk… More »